Surface-enhanced Raman scattering-based detection of cancerous renal cells

Sevda Mert, Mustafa Çulha

Research output: Contribution to journalArticlepeer-review

26 Scopus citations


Surface-enhanced Raman scattering (SERS) is used for the differentiation of human kidney adenocarcinoma, human kidney carcinoma, and non-cancerous human kidney embryonic cells. Silver nanoparticles (AgNPs) are used as substrate in the experiments. A volume of colloidal suspension containing AgNPs is added onto the cultured cells on a CaF2 slide, and the slide is dried at the overturned position. A number of SERS spectra acquired from the three different cell lines are statistically analyzed to differentiate the cells. Principal component analysis (PCA) combined with linear discriminate analysis (LDA) was performed to differentiate the three kidney cell types. The LDA, based on PCA, provided for classification among the three cell lines with 88% sensitivity and 84% specificity. This study demonstrates that SERS can be used to identify renal cancers by combining this new sampling method and LDA algorithms.

Original languageEnglish (US)
Pages (from-to)617-624
Number of pages8
JournalApplied Spectroscopy
Issue number6
StatePublished - Jun 1 2014
Externally publishedYes


  • Differentiation
  • Principal component analysis-linear discriminate analysis
  • Renal carcinoma
  • SERS
  • Single cell
  • Surface-enhanced Raman scattering

ASJC Scopus subject areas

  • Instrumentation
  • Spectroscopy


Dive into the research topics of 'Surface-enhanced Raman scattering-based detection of cancerous renal cells'. Together they form a unique fingerprint.

Cite this